Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,442
Closed -$534K – 824
2026
Q1
$534K Buy
+4,442
New +$513K 0.13% 292
2025
Q3
– Sell
-11,900
Closed -$942K – 847
2025
Q2
$942K Buy
+11,900
New +$946K 0.22% 164
2025
Q1
– Sell
-11,197
Closed -$1.11M – 732
2024
Q4
$1.11M Buy
+11,197
New +$1.15M 0.25% 140
2024
Q3
– Sell
-7,812
Closed -$967K – 794
2024
Q2
$967K Buy
+7,812
New +$1.01M 0.27% 109
2024
Q1
– Sell
-2,744
Closed -$299K – 667
2023
Q4
$299K Sell
2,744
-3,193
-54% -$331K 0.21% 221
2023
Q3
$611K Buy
+5,937
New +$640K 0.35% 103
2023
Q2
– Sell
-6,647
Closed -$707K – 557
2023
Q1
$707K Buy
+6,647
New +$718K 0.23% 172

Other funds holding MRK

InceptionR's MRK Position: Q2 2026 in Review

InceptionR sold out of Merck (MRK) in Q2 2026, closing a stake of 4,442 shares — an estimated $534K sold.

InceptionR first reported a position in MRK in Q1 2023 and held it in 7 quarters. The position peaked at $1.11M in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • InceptionR reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • InceptionR sold 4,442 Merck shares in Q2 2026, an estimated $534K.
  • InceptionR first reported a position in Merck in Q1 2023 and held it in 7 quarters.
  • InceptionR's Merck position peaked at $1.11M in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.